The six most-searched oral health symptoms associated with GLP-1 use tell the story clearly: Dry mouth / xerostomia Halitosis and bad breath Metallic taste in mouth Tooth sensitivity Every one of them is a direct downstream consequence of reduced saliva flow, and collectively they generated over 250,000 searches across the US in 2024
Get a thorough, pre-procedure medical evaluation
In This Article [show] What GLP-1s Do to Bone: The Hansen Trial The most rigorous bone-specific data on GLP-1 therapy comes from Hansen et al
The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
David Perlmutter, a neurologist at The Perlmutter Health Center, oversaw a human pilot study on the use of IV glutathione for PD, the results of which he published in Movement Disorders
it represents a fundamental choice in research strategy: are you targeting a precise enzymatic pathway or supporting a broader metabolic system